Abstract
Accurate clinical staging of patients with non—small cell lung cancer (NSCLC) is essential to optimize treatment and outcomes. This article discusses current perspectives on the surgical treatment of lung cancer, including the revised European Society of Thoracic Surgeons guidelines for preoperative mediastinal lymph node staging for NSCLC. Also discussed are how improvements in imaging and the use of computed tomography imaging for diagnostic workup and screening have led to many small lung cancers being found.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
